Amy L Gawad
Overview
Explore the profile of Amy L Gawad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park H, Yin A, Barranta C, Lee J, Caputo C, Sachithanandham J, et al.
JCI Insight
. 2024 Mar;
9(8.
PMID: 38483534
BACKGROUNDCOVID-19 convalescent plasma (CCP) virus-specific antibody levels that translate into recipient posttransfusion antibody levels sufficient to prevent disease progression are not defined.METHODSThis secondary analysis correlated donor and recipient antibody levels...
2.
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"
Gebo K, Heath S, Fukuta Y, Zhu X, Baksh S, Abraham A, et al.
mBio
. 2023 Dec;
15(1):e0297923.
PMID: 38095433
No abstract available.
3.
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial
Habtehyimer F, Zhu X, Redd A, Gebo K, Abraham A, Patel E, et al.
Microbiol Spectr
. 2023 Nov;
12(1):e0328623.
PMID: 38009954
This study examined the role that cytokines may have played in the beneficial outcomes found when outpatient individuals infected with SARS-CoV-2 were transfused with COVID-19 convalescent plasma (CCP) early in...
4.
Gebo K, Heath S, Fukuta Y, Zhu X, Baksh S, Abraham A, et al.
mBio
. 2023 Sep;
14(5):e0061823.
PMID: 37724870
Approximately 20% of individuals infected with SARS-CoV-2 experienced long-term health effects, as defined PCC. However, it is unknown if there are any early biomarkers associated with PCC or whether early...
5.
Zhu X, Gebo K, Abraham A, Habtehyimer F, Patel E, Laeyendecker O, et al.
Lancet Microbe
. 2023 Sep;
4(9):e692-e703.
PMID: 37659419
Background: Cytokines and chemokines play a critical role in the response to infection and vaccination. We aimed to assess the longitudinal association of COVID-19 vaccination with cytokine and chemokine concentrations...
6.
Huaman M, Raval J, Paxton J, Mosnaim G, Patel B, Anjan S, et al.
Transfusion
. 2023 Aug;
63(9):1639-1648.
PMID: 37534607
Background: COVID-19 convalescent plasma (CCP) is an important therapeutic option for outpatients at high risk of hospitalization from SARS-CoV-2 infection. We assessed the safety of outpatient CCP transfusions administered during...
7.
Park H, Yin A, Barranta C, Lee J, Caputo C, Sachithanandham J, et al.
medRxiv
. 2023 May;
PMID: 37131659
Background: The COVID-19 convalescent plasma (CCP) viral specific antibody levels that translate into recipient post-transfusion antibody levels sufficient to prevent disease progression is not defined. Methods: This secondary analysis correlated...
8.
Gebo K, Heath S, Fukuta Y, Zhu X, Baksh S, Abraham A, et al.
medRxiv
. 2023 Feb;
PMID: 36824860
Background: Post-COVID conditions (PCC) are common and have significant morbidity. Risk factors for PCC include advancing age, female sex, obesity, and diabetes mellitus. Little is known about early treatment, inflammation,...
9.
Shoham S, Bloch E, Casadevall A, Hanley D, Lau B, Gebo K, et al.
Clin Infect Dis
. 2022 May;
76(3):e477-e486.
PMID: 35579509
Background: The efficacy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent plasma (CCP) for preventing infection in exposed, uninfected individuals is unknown. CCP might prevent infection when administered before...
10.
Sullivan D, Gebo K, Shoham S, Bloch E, Lau B, Shenoy A, et al.
N Engl J Med
. 2022 Mar;
386(18):1700-1711.
PMID: 35353960
Background: Polyclonal convalescent plasma may be obtained from donors who have recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing serious complications in outpatients with recent-onset...